World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
26918
World Ranking
15546
National Ranking
606

Massimo Libra publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Massimo Libra sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 400 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Massimo Libra D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Massimo Libra sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Massimo Libra is affiliated with the University of Catania in Italy and has contributed extensively to biomedical research, particularly in medicine and biochemistry, genetics, and molecular biology. With a research portfolio of 134 publications in medicine and 107 in biochemistry and molecular biology, their work covers a wide range of interdisciplinary scientific topics.

The primary subfields of study for Massimo Libra include molecular biology, oncology, cancer research, infectious diseases, and immunology. Their research addresses critical topics such as microRNA in disease regulation, cancer-related molecular mechanisms, epigenetics and DNA methylation, nutritional studies and diet, cancer immunotherapy and biomarkers, diet and metabolism studies, and COVID-19 clinical research studies.

Among the recent publications, notable papers include:

  • "Targeting GSK3 and Associated Signaling Pathways Involved in Cancer" (2020) in Cells
  • "Sensitivity assessment of droplet digital PCR for SARS-CoV-2 detection" (2020) in International Journal of Molecular Medicine
  • "SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19" (2020) in Food and Chemical Toxicology
  • "Current and innovative methods for the diagnosis of COVID-19 infection (Review)" (2021) in International Journal of Molecular Medicine
  • "Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma" (2020) in Cells

Massimo Libra has collaborated frequently with several researchers. The most frequent co-authors are:

  • Luca Falzone
  • Saverio Candido
  • Silvia Vivarelli
  • Giuseppe Gattuso
  • Benjamin Bonavida

Their studies have been published in multiple scientific journals. The most common venues include:

  • International Journal of Molecular Sciences
  • Nutrients
  • Cancers
  • International Journal of Molecular Medicine
  • International Journal of Oncology

Best Publications

  • ROLES OF THE RAF/MEK/ERK PATHWAY IN CELL GROWTH, MALIGNANT TRANSFORMATION AND DRUG RESISTANCE

    James A. McCubrey;Linda S. Steelman;William H. Chappell;Stephen L. Abrams

  • Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.

    James A. McCubrey;Linda S. Steelman;Steven L. Abrams;John T. Lee

  • Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging

    Linda S. Steelman;William H. Chappell;Stephen L. Abrams;C. Ruth Kempf

  • Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium.

    Luca Falzone;Salvatore Salomone;Massimo Libra

  • Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health

    William H. Chappell;Linda S. Steelman;Jacquelyn M. Long;Ruth C. Kempf

  • Gut Microbiota and Cancer: From Pathogenesis to Therapy

    Silvia Vivarelli;Rossella Salemi;Saverio Candido;Luca Falzone

  • Cutaneous melanoma: From pathogenesis to therapy (Review)

    Giulia C. Leonardi;Luca Falzone;Rossella Salemi;Antonino Zanghì

  • GSK-3 as potential target for therapeutic intervention in cancer.

    James A. McCubrey;Linda S. Steelman;Fred E. Bertrand;Nicole Marie Davis

  • Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia

    L. S. Steelman;S. L. Abrams;J. Whelan;F. E. Bertrand

  • Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)

    George Mihai Nitulescu;Denisa Margina;Petras Juzenas;Qian Peng

  • Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mtor cascades which alter therapy response

    James A McCubrey;Linda S Steelman;William H Chappell;Stephen L Abrams

  • Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance

    James Andrew McCubrey;Linda S. Steelman;William H. Chappell;Stephen L. Abrams

  • Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy.

    L S Steelman;R A Franklin;S L Abrams;W Chappell

  • Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention

    Nicole Marie Davis;Melissa Sokolosky;Kristin Stadelman;Stephen L. Abrams

  • Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy

    J A McCubrey;L S Steelman;S L Abrams;F E Bertrand

  • Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention

    James A. McCubrey;L. S. Steelman;Fred E. Bertrand;Nicole Marie Davis

  • Targeting the leukemic stem cell: the Holy Grail of leukemia therapy

    Negin Misaghian;Giovanni Ligresti;L. S. Steelman;Fred E. Bertrand

  • PIK3CA mutations in human solid tumors: role in sensitivity to various therapeutic approaches.

    Giovanni Ligresti;Loredana Militello;Linda S. Steelman;Andrea Cavallaro

  • Targeting the translational apparatus to improve leukemia therapy: Roles of the PI3K/PTEN/Akt/mTOR pathway

    A. M. Martelli;C. Evangelisti;W. Chappell;S. L. Abrams

  • Akt as a therapeutic target in cancer.

    Linda S Steelman;Kristin M Stadelman;William H Chappell;Stefan Horn

Frequent Co-Authors

James A. McCubrey
James A. McCubrey East Carolina University
Alberto M. Martelli
Alberto M. Martelli University of Bologna
Giuseppe Montalto
Giuseppe Montalto University of Palermo
Lucio Cocco
Lucio Cocco University of Bologna
Melchiorre Cervello
Melchiorre Cervello National Research Council (CNR)
Maurizio Montella
Maurizio Montella Regione Campania
Diego Serraino
Diego Serraino University of Oxford
Demetrios A. Spandidos
Demetrios A. Spandidos University of Crete
Marco Donia
Marco Donia Copenhagen University Hospital
Carlo La Vecchia
Carlo La Vecchia University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a future in medicine offers more than just the traditional path to becoming a physician. Today, a range of related online degrees and certifications provide alternative routes to build a rewarding healthcare career.

For nurses aiming to reach the highest clinical levels, the best online DNP programs deliver advanced training and leadership skills with the flexibility of remote learning. If pharmacy interests you, pursuing pharmacy school online opens doors to the pharmaceutical industry, clinical pharmacy, and research, all from home.

Careers on the administrative side are also in demand. Earning credentials through rhia certification programs online can lead to roles managing medical records and health data systems—a vital function in modern healthcare. Similarly, those interested in the business and compliance aspects can consider medical billing and coding certification online for a quick entry into the workforce.

These pathways offer diverse opportunities for students passionate about healthcare. By choosing a program that fits your goals, you can build a meaningful, secure career in the evolving medical field.

Best Scientists Citing Massimo Libra

Trending Scientists

Recently Published Articles